Hikma PHarmaceuticals Plc annual rePort 2013 notes to tHe comPany financialstatements Continued 56. sHare Premium share premium $m balance at 1 January 2013 279 premium arising on exercise of stock options 2 Balance at 31 December 2013 281 57. net income for tHe year as permitted by section 408 of the companies act 2006, the statement of comprehensive income of the company is not presented as part ofthese accounts.
the net income in the company for the year is $35 million 2012: $602 million.
included in the net income for the year is an amount of $56 million 2012: $614 million representing dividends received and $1 million 2012: $2 million representing the current year charge of ltiPs.
the remaining $6 million 2012: $6 million of the groups stock options, ltiPs and miPs charge is recharged to subsidiary companies.
58. relateD Parties Darhold Limited: is a related party of the company because it is considered one of the major shareholders of Hikma Pharmaceuticals Plc with ownership percentage of 28.9% at the end of 2013 2012: 29.0%.
further details on the relationship between mr. samih Darwazah, mr. said Darwazah, mr. mazen Darwazah and mr. ali al-Husry, and Darhold limited are given in the Directors report.
Arab Bank: is a related party of the company because one Hikma Pharmaceuticals Plc senior management member is also a Board member of arab Bank Plc.
total cash balances at arab Bank were $5.3 million 31 December 2012: $5.0 million.
facilities granted by arab Bank tothecompany amounted to $91.6 million 31 December 2012: $85.0 million.
interest expense income is within market rate.
amounts repayable to and from subsidiaries are disclosed in notes 45 and 48. other transactions with related parties include management charges for services provided to the subsidiary companies, equity-settled employee share scheme costs relating to the subsidiary companies and transactions with key management personnel.
compensation paid to key management personnel is disclosed in note 38.
Details of Directors remuneration are disclosed in the remuneration committee report onpages86 to 115. more details on the general information of the ultimate parent of the group are disclosed in note 2.
